Mick Radio-Nuclear Instruments

What Mick Radio-Nuclear Instruments does

Mick Radio-Nuclear Instruments, Inc. is a US-based manufacturer of precision brachytherapy instrumentation and accessories, headquartered in Mount Vernon, New York. The company designs and produces medical devices used by hospitals and radiation therapy centers for the treatment of prostate and gynecological cancers, with a 40-plus-year operating history and self-described international reputation as the 'Gold Standard' in brachytherapy instrumentation. Its product portfolio spans brachytherapy instrumentation, high-dose-rate (HDR) brachytherapy systems with afterloading equipment, treatment planning software for dose calculation, clinically proven X-ray therapy products, and innovative intraoperative radiation therapy products.

The company operates as a wholly-owned subsidiary of BEBIG Medical GmbH, a German medical technology company, following an acquisition completed in 2021. Under this structure, Mick Radio-Nuclear Instruments functions as BEBIG Medical's global manufacturing factory and its dedicated operation office for the American market, integrating the parent's broader radiation therapy portfolio with its legacy brachytherapy focus. The CEO of BEBIG Medical, George Chan — a former President of Siemens Healthineers Greater China with oversight of more than 7,000 employees and €1.8 billion in turnover — leads the operational business covering Mick Radio-Nuclear Instruments.

The business model is built on direct enterprise field sales of medical hardware and related consumables to hospitals and radiation therapy centers, supported by a dedicated US sales team reachable via phone, toll-free line, fax, and [email protected]. Pricing is quote-based and not publicly disclosed, and products are not distributed in all markets without engaging a local representative. Distribution leverages BEBIG Medical's global network beyond the US, and the company's marketing presence is concentrated on its own website and BEBIG Medical's LinkedIn and YouTube channels. No public funding rounds, revenue disclosures, or named customer relationships are reported in the available data.

Name

Mick Radio-Nuclear Instruments

Legal name

Mick Radio-Nuclear Instruments, Inc.

Website

https://micknuclear.com

Company type

Private

Founded year

1980

Operating status

Operating

Headcount range

101–250 employees

Short description

Mick Radio-Nuclear Instruments manufactures brachytherapy instrumentation for hospitals and radiation therapy centers treating prostate and gynecological cancers. A subsidiary of BEBIG Medical GmbH since 2021, it serves as the parent's global factory and US market operation office.

Ownership category

akta.pro rank

Product category

Radiation Therapy Equipment

NAICS

Irradiation Apparatus Manufacturing (334517), Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841), X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844)

akta.pro primary industry

Radiation Therapy Isotopes & Sources (Brachytherapy seeds, sealed sources for oncology) (EUAKAIAD)

akta.pro secondary industry

Radiation Oncology (HLAKAFAC)

Keywords

• Brachytherapy instrumentation
• Radiation therapy devices
• HDR afterloading systems
• Treatment planning software
• Intraoperative radiation therapy

Headquarters

HQ city

Mount Vernon

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Medical Device and Equipment Sales: Sale of brachytherapy instruments, afterloading systems, treatment planning systems, X-ray therapy products, and intraoperative radiation therapy products. Hardware sales model with associated consumables and replacement parts for radiation therapy equipment.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Mick Radio-Nuclear Instruments, Inc. manufactures precision brachytherapy instrumentation and accessories used in radiation therapy and brachytherapy procedures, with particular focus on prostate and gynecological cancer treatment. Its portfolio includes HDR brachytherapy afterloading systems, treatment planning software for dose calculation and optimization, clinically proven X-ray therapy products, and innovative intraoperative radiation therapy products, sold to hospitals and radiation therapy centers.

Product overview

Mick Radio-Nuclear Instruments, Inc. is a BEBIG Medical company and a subsidiary of BEBIG Medical GmbH since 2021, acting as a global factory and operation office for the American market. The company provides a comprehensive portfolio of brachytherapy technology products, including HDR Brachytherapy Systems with afterloading equipment, Treatment Planning Systems for dose calculation, X-ray Therapy Products, and Intraoperative Radiation Therapy Products. The company is internationally known for over 40 years of service to the radiation therapy and brachytherapy communities, with particular focus on prostate and gynecological brachytherapy applications.

Differentiator

Problem solved

Functional benefit

Products and services

• Brachytherapy Instrumentation

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• BEBIG Medical GmbHcoreStrategic or Co-development Partner · 1 January 2021Since 2021, Mick Radio-Nuclear Instruments, Inc. became a subsidiary of BEBIG Medical GmbH. Mick Radio-Nuclear acts as a global factory as well as an operation office for American market. BEBIG Medical provides state-of-the-art afterloading and treatment planning systems for HDR brachytherapy, clinical proven X-ray therapy product series, and innovative intraoperative radiation therapy products.

Scale indicators2 records

Recent moves4 records

Expansion highlights5 records

Emerging players

• IsoRay Medical: Specializes in Cesium-131 brachytherapy seeds for prostate, brain, and other cancers. Niche competitor in the brachytherapy source market that Mick's afterloading systems are designed to deliver.
• Mevion Medical Systems: Compact proton therapy system developer. Adjacent competitor in advanced radiation therapy, providing an alternative modality to brachytherapy for certain cancers.
• ViewRay: MR-guided radiation therapy (MRIdian) developer. Competes in the radiation oncology modality market that surrounds brachytherapy decision-making, influencing whether Mick's customers select brachytherapy vs. adaptive EBRT.

Direct peers

• Elekta: Global leader in radiation therapy and radiosurgery, including a major brachytherapy portfolio (Flexitron afterloaders, Oncentra treatment planning). Directly competes with Mick/BEBIG in HDR brachytherapy for prostate, gynecological, and other indications.
• BEBIG Medical GmbH: Mick's parent company and the source of its broader HDR brachytherapy, treatment planning, X-ray therapy, and intraoperative radiation therapy products. Operates overlapping product lines globally through Mick as its US arm.
• Best Medical International: Manufactures brachytherapy products including seeds, surface applicators, and accessories. Competes with Mick in the brachytherapy instrumentation and accessories market.
• Theragenics: Manufactures brachytherapy seeds (e.g., Pd-103, I-125, AgX100) and related accessories for prostate and other cancers. Directly comparable as a focused brachytherapy source/device manufacturer.

Broad incumbents

• Carl Zeiss Meditec: Broad ophthalmology and surgical visualization/microscopy platform; intraoperative radiation therapy is adjacent to its surgical suite offerings, and the company competes in radiation oncology-adjacent clinical workflows.
• Varian Medical Systems (a Siemens Healthineers company): Dominant radiation oncology OEM offering linacs, brachytherapy afterloaders (GammaMedplus/Varian HDR), and Eclipse treatment planning. Competes with Mick in brachytherapy while bundling into a broader oncology platform.
• Accuray: Manufactures CyberKnife and TomoTherapy radiation therapy systems; competes with Mick-adjacent radiation therapy offerings and increasingly overlaps in image-guided and hypofractionated treatment workflows.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCmN5J1NcyECqO5-IYJ60dyA
• LinkedInlinkedin.com/company/bebig-medical

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mick Radio-Nuclear Instruments